Raloxifene hydrochloride
NDC 50228-306, Raloxifene hydrochloride, tablet, film coated, from ScieGen Pharmaceuticals Inc.
- Product NDC
- 50228-306
- Status
- Listed
- Labeler
- ScieGen Pharmaceuticals Inc
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206384
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50228-306 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RALOXIFENE HYDROCHLORIDE60 mg/1
Pharmacologic classes
Estrogen Agonist/Antagonist [EPC]; Selective Estrogen Receptor Modulators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50228-306-20 | 50228030620 | 2000 TABLET, FILM COATED in 1 BOTTLE (50228-306-20) |
| 50228-306-30 | 50228030630 | 30 TABLET, FILM COATED in 1 BOTTLE (50228-306-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/8152e68b-61a8-4897-8e03-900135b1dbd5
Use it
Look up 50228-306 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50228-306 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50228-306. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.